OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
|Articles|February 1, 2006
- Volume 0 0
ViaNase ID
Advertisement
Kurve Technology Inc (Bothell,Wash)recently introduced its first nasal drugdelivery device—ViaNase ID. The productincorporates drug identification and lockouttechnologies, data transfer, and anelectronic display. The features not onlyimprove patient compliance but mayprove vital in curbing the counterfeit drugmarket. ViaNase ID uses the company'sControlled Participle Dispersion technologyto control which drugs are used inthe device. The attempted use of anunapproved drug renders the deviceinoperable. The product records the drugname, product code, and expiration date.ViaNase ID also simplifies the administrationof drugs delivered nasally. On theelectronic display, patients can see thenumber of doses delivered, number ofdoses left in the prescription, as well asreceive alarm reminders when it is timeto administer the drug. For more information,visit www.kurvetech.com.
Articles in this issue
almost 21 years ago
can you READ these Rxs?almost 21 years ago
Compounding HOTLINEalmost 21 years ago
A Quarter Century of Pharmacy Law—And the Fat Lady Is Singingalmost 21 years ago
It's Time for Education on Rx Drug Abusealmost 21 years ago
Improving Quality of Life for Psoriasis Patientsalmost 21 years ago
A Look at Diabetic Retinopathyalmost 21 years ago
The Graying of HIValmost 21 years ago
AutoCarouselalmost 21 years ago
Lexi-Comp Knowledge Solutionalmost 21 years ago
Refill TeleManagerAdvertisement
Related to this article
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
3
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5